Company: CORT
Filing Date: 2025-07-31
Form Type: 10-Q
Source: 0001628280-25-037005
Chunk: 36

Company: CORCEPT THERAPEUTICS INC
Filing Date: 2025-07-31
Form: 10-Q
Item: Part I, Item 8
Chunk 36
---
 progress inventory. We classify inventory we do not expect to utilize within 12 months of the balance sheet date as “strategic inventory,” a non-current asset.Prepaid expenses and other current assetsJune 30,2025December 31,2024(in thousands)Prepaid expenses$9,693 $9,492 Deferred clinical materials4,401 4,493 Clinical deposits2,479 1,817 Other current assets7,470 6,078 Total prepaid expenses and other current assets$24,043 $21,880 Accrued and other liabilitiesJune 30,2025December 31,2024 (in thousands)Government rebates$50,866 $41,580 Accrued compensation26,281 41,731 Accrued selling and marketing costs7,042 3,345 Other6,884 4,044 Total accrued and other liabilities$91,073 $90,700 

11

3. Available-for-Sale Marketable Securities and Fair Value Measurements

The available-for-sale securities in our condensed consolidated balance sheets are as follows:June 30,2025December 31,2024(in thousands)Cash equivalents$72,303 $98,436 Short-term marketable securities239,481 255,669 Long-term marketable securities172,775 219,831 Total marketable securities$484,559 $573,936 The following table presents our available-for-sale securities grouped by asset type: Fair ValueHierarchyLevelJune 30, 2025December 31, 2024Amortized CostGross Unrealized GainsGross Unrealized LossesEstimated Fair ValueAmortized CostGross Unrealized GainsGross Unrealized LossesEstimated Fair Value  (in thousands)Corporate bondsLevel 2$324,928 $637 $(124)$325,441 $373,440 $333 $(529)$373,244 Commercial paperLevel 26,903 1 (2)6,902 9,771 6 (2)9,775 U.S. government agency securitiesLevel 234,990 5 (25)34,970 7,999 — (2)7,997 U.S. Treasury securitiesLevel 144,944 5 (6)44,943 84,458 27 (1)84,484 Money market fundsLevel